Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination.
Mol Cancer Res. 2019 Oct;17(10):1985-1998. doi: 10.1158/1541-7786.MCR-18-1335. Epub 2019 Jul 12.
Mol Cancer Res. 2019.
PMID: 31300540
Free PMC article.
MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1.
Jillson LK, Rider LC, Rodrigues LU, Romero L, Karimpour-Fard A, Nieto C, Gillette C, Torkko K, Danis E, Smith EE, Nolley R, Peehl DM, Lucia MS, Costello JC, Cramer SD.
Jillson LK, et al.
Mol Cancer Res. 2021 Jul;19(7):1123-1136. doi: 10.1158/1541-7786.MCR-20-0913. Epub 2021 Apr 12.
Mol Cancer Res. 2021.
PMID: 33846123
Free PMC article.
Item in Clipboard
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes.
Jillson LK, Yette GA, Laajala TD, Tilley WD, Costello JC, Cramer SD.
Jillson LK, et al.
Cancers (Basel). 2021 Jun 30;13(13):3272. doi: 10.3390/cancers13133272.
Cancers (Basel). 2021.
PMID: 34208794
Free PMC article.
Review.
Item in Clipboard
Cite
Cite